NCT05057962View on ClinicalTrials.gov

Tocilizumab in Covid-19 Penumonia in Buenos Aires City

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

September 7, 2021

Study Completion Date

May 4, 2022

Conditions
COVID-19 PneumoniaTocilizumab
Trial Locations (1)

1187

Nazareno Galvalisi, Buenos Aires

All Listed Sponsors
lead

Sanatorio Finochietto

OTHER